Dr. Fumio  Tsuji

Dr. Fumio Tsuji

Research Scientist
Santen Pharmaceutical Co., Ltd., Japan


Highest Degree
Ph.D. in Pharmaceutical Sciences from Gifu University, Gifu, Japan

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Immunopharmacology
62%
Pharmaceutical Sciences
90%
Pharmacogenetics
75%
Leukotriene
55%

Selected Publications

  1. Tsukahara-Ohsumi, Y., F. Tsuji, M. Niwa, M. Nakamura and K. Mizutani et al., 2010. SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects. Eur. J. Pharmacol., 647: 62-67.
    CrossRef  |  PubMed  |  Direct Link  |  

  2. Tsuji, F., M. Murai, K. Oki, I. Seki and K. Ueda et al., 2010. Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents. Eur. J. Pharmacol., 627: 332-339.
    CrossRef  |  PubMed  |  Direct Link  |  

  3. Tsuji, F., H. Aono, T. Tsuboi, T. Murakami, H. Enomoto, K. Mizutani and N. Inagaki, 2010. Role of leukotriene B4 in 5-lipoxygenase metabolite- and allergy-induced itch-associated responses in mice. Biol. Pharm. Bull., 33: 1050-1053.
    CrossRef  |  PubMed  |  Direct Link  |  

  4. Setoguchi, C., F. Tsuji, O. Katsuta, M. Okamoto and H. Aono, 2010. Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model. Mod. Rheumatol., 20: 381-388.
    CrossRef  |  PubMed  |  Direct Link  |  

  5. Tsuji, F., M. Yoshimi, O. Katsuta, M. Takai, K. Ishihara and H. Aono, 2009. Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice. BMC Musculoskelet. Disord., 10: 23-23.
    CrossRef  |  PubMed  |  Direct Link  |